Nu Holdings stock beats the market in thin year-end trade — what NU investors are watching next

Nu Holdings stock beats the market in thin year-end trade — what NU investors are watching next

NEW YORK, December 30, 2025, 22:12 ET — Market closed

  • Nu Holdings (NU) rose 1.3% to $16.88 on Tuesday, outpacing a 0.14% dip in the S&P 500.
  • Latin America fintech peers StoneCo and Inter & Co gained, while SoFi slipped.
  • Analysts’ forecasts ahead of Nu’s next earnings update are back in focus after the stock’s recent monthly pullback.

Nu Holdings Ltd. (NYSE: NU) shares climbed 1.3% to $16.88 on Tuesday, ending higher even as Wall Street posted a modest decline in the penultimate session of 2025.

The move mattered because liquidity is thin into year-end, which can magnify day-to-day swings and drive fast rotations between crowded trades and laggards.

For Nu, the bounce comes after a weaker month. The stock has fallen about 4.7% over the past four weeks, leaving investors watching whether the next earnings update can reset sentiment.

Nu traded between $16.60 and $17.11 during the session, with about 31.4 million shares changing hands. The S&P 500 slipped 0.14%, while the Nasdaq Composite fell 0.23% and the Dow lost 0.20%, according to a Reuters market wrap. Reuters

Other fintech names tied to consumer credit were mixed. StoneCo rose about 1.4% and Inter & Co gained about 1.4%, while SoFi Technologies fell about 1.0%, based on end-of-day market data.

“It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide, commenting on broader year-end positioning.

Nu, which operates the Nubank digital banking platform across Latin America, is often treated as a high-beta proxy for risk appetite in emerging-market fintech.

Analysts tracked by Zacks expect Nu to post earnings per share of $0.18 on its next report, on revenue of $4.56 billion, according to a note republished by Nasdaq on Tuesday. The same note pegged Nu’s forward price-to-earnings ratio — a valuation measure based on expected profits — at about 28.4, and its PEG ratio, which adjusts P/E for expected growth, at roughly 0.8. Nasdaq

Nu’s next earnings date is widely listed as falling in February, with Nasdaq’s earnings page showing an estimated report date of Feb. 19, 2026. Investors typically use that window to look for updates on loan growth, funding costs and credit performance — a key watchpoint for consumer lenders. Nasdaq

Wednesday marks the final trading day of 2025, before U.S. markets close for the New Year’s Day holiday. Volume is likely to stay light, keeping the tape sensitive to positioning.

In the near term, traders will watch whether NU can hold above Tuesday’s $16.60 low and challenge the $17.11 intraday high, which sits near a round-number level that can draw momentum flows.

Beyond the next session, the focus shifts to Nu’s upcoming results and how management frames 2026. Investors will be looking for evidence that customer growth and monetization can stay strong without a rise in delinquencies as the company expands credit across its markets.

Stock Market Today

  • Sonic Healthcare Share Price Down 15% in 2025 Amid Dividend and Valuation Debate
    January 21, 2026, 11:10 AM EST. Sonic Healthcare (ASX:SHL) has seen a 15% share price decline since 2025 began, prompting renewed attention on its valuation and dividend strategy. Despite a mixed short-term performance, the stock's 1-year total shareholder return is down by 12.94%, reflecting investor caution post-pandemic. The company trades at a price-to-earnings (P/E) ratio of 22.4x, above the global healthcare average of 19.7x but below its fair value estimate of 41.2x, suggesting a potential discount of 61.2%. Analysts are divided, balancing Sonic's earnings decline of 16% annually over five years against steady revenue growth and future cash flow prospects. The market continues to weigh risks, including potential shortfalls in earnings and changing market assumptions, making Sonic Healthcare a focal point for healthcare investors reassessing sector opportunities.
Eaton stock slips as Fed minutes cap thin year-end session; ETN traders eye jobless claims next
Previous Story

Eaton stock slips as Fed minutes cap thin year-end session; ETN traders eye jobless claims next

IBM stock slips in thin year-end trade as tech rotation bites; eyes turn to Jan. 28 earnings
Next Story

IBM stock slips in thin year-end trade as tech rotation bites; eyes turn to Jan. 28 earnings

Go toTop